Evidence map›Paper›PMID 32786875›Full record

ArticleJournal of natural products2020

Allicin, a Potent New Ornithine Decarboxylase Inhibitor in Neuroblastoma Cells.

Chad R Schultz, Martin C H Gruhlke, Alan J Slusarenko, André S Bachmann

Open access · greenAbstract read
In one paragraph

Article in Journal of natural products, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Bachmann-Bupp syndrome and treatment.Developmental medicine and child neurology · 2024
    Review
  6. Article
  7. Article
  8. A newAmino acids · 2023
    Article
  9. Review
  10. Structural Basis for Allostery in PLP-dependent Enzymes.Frontiers in molecular biosciences · 2022
    Review
  11. Antitumor Effects of Natural Compounds Derived fromAntioxidants (Basel, Switzerland) · 2021
    Review
  12. Garlic (Antioxidants (Basel, Switzerland) · 2021
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. In vivo (Athens, Greece)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Chad R SchultzDepartment of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan 49503, United States.
Martin C H GruhlkeDepartment of Plant Physiology, RWTH Aachen University, 52056 Aachen, Germany.
Alan J SlusarenkoDepartment of Plant Physiology, RWTH Aachen University, 52056 Aachen, Germany.
André S BachmannDepartment of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan 49503, United States.ORCID 0000-0002-6510-8560
Michigan State University · USRWTH Aachen University · DE

Funding

Novel ODC Inhibitor Phaseolotoxin in NeuroblastomaR21CA216867 · NCI · MICHIGAN STATE UNIVERSITY · PI BACHMANN, ANDRE S · 2018 to 2019
$453k
NCI NIH HHS R21 CA216867
6 · The paper itself

Abstract

The natural product allicin is a reactive sulfur species (RSS) from garlic (

Indexed as

Amino Acid SequenceAntineoplastic Agents, PhytogenicApoptosisCell Line, TumorCell ProliferationDisulfidesHumansNeuroblastomaOrnithine DecarboxylaseOrnithine Decarboxylase InhibitorsSulfinic AcidsallicinAntineoplastic Agents, PhytogenicDisulfidesOrnithine DecarboxylaseOrnithine Decarboxylase InhibitorsSulfinic Acids

Identifiers

PMID32786875
PMCPMC9162488
OpenAlexW3048425725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.